Vitamin D Levels, Lung Function, and Steroid Response in Adult Asthma
Overview
Affiliations
Rationale: Patients with asthma exhibit variable response to inhaled corticosteroids (ICS). Vitamin D is hypothesized to exert effects on phenotype and glucocorticoid (GC) response in asthma.
Objectives: To determine the effect of vitamin D levels on phenotype and GC response in asthma.
Methods: Nonsmoking adults with asthma were enrolled in a study assessing the relationship between serum 25(OH)D (vitamin D) concentrations and lung function, airway hyperresponsiveness (AHR), and GC response, as measured by dexamethasone-induced expression of mitogen-activated protein kinase phosphatase (MKP)-1 by peripheral blood mononuclear cells.
Measurements And Main Results: A total of 54 adults with asthma (FEV(1), 82.9 +/- 15.7% predicted [mean +/- SD], serum vitamin D levels of 28.1 +/- 10.2 ng/ml) were enrolled. Higher vitamin D levels were associated with greater lung function, with a 22.7 (+/-9.3) ml (mean +/- SE) increase in FEV(1) for each nanogram per milliliter increase in vitamin D (P = 0.02). Participants with vitamin D insufficiency (<30 ng/ml) demonstrated increased AHR, with a provocative concentration of methacholine inducing a 20% fall in FEV(1) of 1.03 (+/-0.2) mg/ml versus 1.92 (+/-0.2) mg/ml in those with vitamin D of 30 ng/ml or higher (P = 0.01). In ICS-untreated participants, dexamethasone-induced MKP-1 expression increased with higher vitamin D levels, with a 0.05 (+/-0.02)-fold increase (P = 0.02) in MKP-1 expression observed for each nanogram per milliliter increase in vitamin D, a finding that occurred in the absence of a significant increase in IL-10 expression.
Conclusions: In asthma, reduced vitamin D levels are associated with impaired lung function, increased AHR, and reduced GC response, suggesting that supplementation of vitamin D levels in patients with asthma may improve multiple parameters of asthma severity and treatment response. Clinical trials registered with www.clinicaltrials.gov (NCT00495157, NCT00565266, and NCT00557180).
Khalil B, Sharif-Askari N, Selvakumar B, Mdkhana B, Hachim I, Zakri A Inflamm Res. 2025; 74(1):51.
PMID: 40082319 DOI: 10.1007/s00011-025-02009-4.
Li T, Wang Q, Li Y, Zhang W, Chen M, Deng B Nutr J. 2025; 24(1):26.
PMID: 39955522 PMC: 11829343. DOI: 10.1186/s12937-024-01065-6.
Serum Vitamin D Level Is Unchanged in Equine Asthma.
Mainguy-Seers S, Holcombe S, Lavoie J Animals (Basel). 2024; 14(22).
PMID: 39595361 PMC: 11591496. DOI: 10.3390/ani14223310.
Ki M, Kim N, Woo A, Kim S, Kim Y, Kim H Transpl Int. 2024; 37:13313.
PMID: 39524045 PMC: 11543412. DOI: 10.3389/ti.2024.13313.
Fedora K, Setyoningrum R, Aina Q, Rosyidah L, Nimah N, Titiharja F Ann Med. 2024; 56(1):2400313.
PMID: 39421966 PMC: 11492411. DOI: 10.1080/07853890.2024.2400313.